Editorial: Best Practices in Surveillance of Barrett's Esophagus.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28725066.
- Also identified by DOI 10.1038/ajg.2017.117.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Endoscopic surveillance in Barrett's esophagus (BE) has numerous limitations and thus provides several opportunities for improving the effectiveness of our current surveillance strategies. Several risk stratification and prediction tools have been investigated to identify patients at highest risk for progression to esophageal adenocarcinoma (EAC). Persistence of non-dysplastic BE (NDBE) has been proposed as an indicator of lower risk of progression to EAC. This editorial highlights the variable results and methodologies in studies evaluating persistence of NDBE as a risk stratification tool in the surveillance of BE patients and provides guidance for optimizing outcomes in BE patients enrolled in surveillance programs.
Medical subject headings
- Adenocarcinoma
- Barrett Esophagus
- Endoscopy, Digestive System
- Esophageal Neoplasms
- Population Surveillance
- Precancerous Conditions